Cervical carcinoma: standard and pharmacokinetic analysis of time-intensity curves for assessment of tumor angiogenesis and patient survival

[1]  G Brix,et al.  Angiogenesis of uterine cervical carcinoma: characterization by pharmacokinetic magnetic resonance parameters and histological microvessel density with correlation to lymphatic involvement. , 1997, Cancer research.

[2]  Scott Fields,et al.  Mapping pathophysiological features of breast tumors by MRI at high spatial resolution , 1997, Nature Medicine.

[3]  M. Neeman,et al.  Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle , 1997, International journal of experimental pathology.

[4]  M. Knopp,et al.  Cervical carcinoma: comparison of standard and pharmacokinetic MR imaging. , 1996, Radiology.

[5]  L D Buadu,et al.  Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. , 1996, Radiology.

[6]  M. Volm,et al.  Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. , 1996, British Journal of Cancer.

[7]  M. Knopp,et al.  Pelvic lesions in patients with treated cervical carcinoma: efficacy of pharmacokinetic analysis of dynamic MR images in distinguishing recurrent tumors from benign conditions. , 1996, AJR. American journal of roentgenology.

[8]  M. Neeman,et al.  Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes , 1995, Molecular and cellular biology.

[9]  M. Mitze,et al.  Tumor vascularity--a novel prognostic factor in advanced cervical carcinoma. , 1995, Gynecologic oncology.

[10]  W. J. Lorenz,et al.  Pharmacokinetic Mapping of the Breast: A New Method for Dynamic MR Mammography , 1995, Magnetic resonance in medicine.

[11]  T. Oostendorp,et al.  Vascularity and perfusion of human gliomas xenografted in the athymic nude mouse. , 1995, British Journal of Cancer.

[12]  D L Wiggins,et al.  Tumor angiogenesis as a prognostic factor in cervical carcinoma. , 1995, Gynecologic oncology.

[13]  M. Neeman,et al.  Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Anthony J. Guidi,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. , 1995, Human pathology.

[15]  M Kunnen,et al.  Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion. , 1994, Radiology.

[16]  T. Kobayashi,et al.  Dynamic MR imaging in the head and neck. , 1993, Radiology.

[17]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[18]  L R Schad,et al.  Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. , 1991, Journal of computer assisted tomography.

[19]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[20]  K J Wolf,et al.  Rheumatoid arthritis: evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. , 1990, Radiology.